高级别脑膜瘤中异常甲基化调控相关基因识别研究

doi:10.3969/j.issn.1006-7795.2023.05.007

首都医科大学学报 ›› 2023, Vol. 44 ›› Issue (5): 747-752.doi: 10.3969/j.issn.1006-7795.2023.05.007

高级别脑膜瘤中异常甲基化调控相关基因识别研究

彭怡琛，郑义，李生兰，于建宇，兰燕杰，刘昕蕊，陈峰，李文斌^*

首都医科大学附属北京天坛医院肿瘤中心神经肿瘤综合治疗病区, 北京 100070

收稿日期:2023-07-18 出版日期:2023-10-20 发布日期:2023-10-25
通讯作者: 李文斌 E-mail:liwenbin@ccmu.edu.cn
基金资助:
北京市临床重点专科项目

Study of genes associated with aberrant methylation regulation in high-grade meningiomas

Peng Yichen, Zheng Yi, Li Shenglan, Yu Jianyu, Lan Yanjie, Liu Xinrui, Chen Feng, Li Wenbin^*

Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China

Received:2023-07-18 Online:2023-10-20 Published:2023-10-25
Supported by:
This study was supported by Clinical Major Specialty Project of Beijing.

摘要/Abstract

摘要： 目的拟通过生物信息学进一步挖掘高级别脑膜瘤潜在的生物标志物及治疗靶点。方法通过公共数据库大数据分析初步了解高级别脑膜瘤恶性程度高的原因，评估其基因组特性及异常甲基化调控的相关基因。结果识别出表达受异常甲基化调控的基因共3 006个，其中突变频率较高的基因210个，挖掘出恶性肿瘤发展、迁移相关通路。结论筛选出高级别脑膜瘤中潜在受异常甲基化调控的基因及相关通路，可作为高级别脑膜瘤的生物标志物及潜在的治疗靶点。

关键词: 高级别脑膜瘤, 异常甲基化, 信号通路

Abstract: Objective To explore potential therapeutic targets with bioinformatics for the treatment of meningiomas, the most common primary central nervous system tumors. Methods A preliminary understanding of the genomic characteristics of high-grade meningiomas was obtained through analysis of public databases to assess the genes associated with aberrant methylation regulation. Results A total of 3 006 genes whose expression was regulated by aberrant methylation were identified, including 210 genes with high mutation frequency, and pathways associated with malignant tumor development and migration were mined. Conclusions Genes and related pathways potentially regulated by aberrant methylation in high-grade meningioma provides bio-markers and potential therapeutic targets for high-grade meningioma.

Key words: high-grade meningioma, aberrant methylation, signaling pathway

中图分类号:

R739.45

彭怡琛, 郑义, 李生兰, 于建宇, 兰燕杰, 刘昕蕊, 陈峰, 李文斌. 高级别脑膜瘤中异常甲基化调控相关基因识别研究[J]. 首都医科大学学报, 2023, 44(5): 747-752.

Peng Yichen, Zheng Yi, Li Shenglan, Yu Jianyu, Lan Yanjie, Liu Xinrui, Chen Feng, Li Wenbin. Study of genes associated with aberrant methylation regulation in high-grade meningiomas[J]. Journal of Capital Medical University, 2023, 44(5): 747-752.

参考文献

［1］Louis D N, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary［J］. Neuro Oncol, 2021, 23(8): 1231-1251.
［2］Ostrom Q T, Gittleman H, Fulop J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012［J］. Neuro Oncol, 2015, 17(Suppl 4): ⅳ1-ⅳ62.
［3］Ostrom Q T, Gittleman H, Xu J, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013［J］. Neuro Oncol, 2016, 18(suppl_5): v1-v75.
［4］Maggio I, Franceschi E, Tosoni A, et al. Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas［J］. CNS Oncol, 2021, 10(2): CNS72.
［5］Simpson D. The recurrence of intracranial meningiomas after surgical treatment［J］. J Neurol Neurosurg Psychiatry, 1957, 20(1): 22-39.
［6］Goldbrunner R, Stavrinou P, Jenkinson M D, et al. EANO guideline on the diagnosis and management of meningiomas［J］. Neuro Oncol, 2021, 23(11): 1821-1834.
［7］Kim L. A narrative review of targeted therapies in meningioma［J］. Chin Clin Oncol, 2020, 9(6): 76.
［8］Xu X M, Peng Q, Jiang X J, et al. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential［J］. Exp Mol Med, 2023, 55(7): 1357-1370.
［9］Zimmerman S M,Lin P N,Souroullas G P. Non-canonical functions of EZH2 in cancer［J］.Front Oncol, 2023, 13: 1233953.
［10］Manna S, Mishra J, Baral T, et al. Epigenetic signaling and crosstalk in regulation of gene expression and disease progression［J］.Epigenomics, 2023, 15(14): 723-740.
［11］Cerami E, Gao A A, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data［J］. Cancer Discov, 2012, 2(5): 401-404.
［12］Higgins D, Shah A H, Komotar R J, et al. Management of atypical and anaplastic meningiomas［J］. Neurosurg Clin N Am, 2023, 34(3): 437-446.
［13］Bi W L, Greenwald N F, Abedalthagafi M, et al. Genomic landscape of high-grade meningiomas［J］. NPJ Genom Med, 2017, 2: 15.
［14］Graillon T, Sanson M, Campello C, et al. Everolimus and octreotide for patients with recurrent meningioma: results from the phase Ⅱ CEVOREM trial［J］. Clin Cancer Res, 2020, 26(3): 552-557.
［15］Marastoni E, Barresi V. Meningioma grading beyond histopathology: relevance of epigenetic and genetic features to predict clinical outcome［J］. Cancers (Basel), 2023, 15(11): 2945.
［16］ Greenberg M V C, Bourchis D. The diverse roles of DNA methylation in mammalian development and disease［J］. Nat Rev Mol Cell Biol, 2019, 20(10): 590-607.
［17］Zhang F F, Zhang X, Zhang H K, et al. Pan-precancer and cancer DNA methylation profiles revealed significant tissue specificity of interrupted biological processes in tumorigenesis［J］. Epigenetics, 2023, 18(1): 2231222.
［18］Bird A, Taggart M, Frommer M, et al. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA［J］. Cell, 1985, 40(1): 91-99.
［19］Jeltsch A, Gowher H. Editorial-role of DNA methyltransferases in the epigenome［J］. Genes (Basel), 2019, 10(8): 574.

高级别脑膜瘤中异常甲基化调控相关基因识别研究

Study of genes associated with aberrant methylation regulation in high-grade meningiomas

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价